Observational studyInternal medicine (Tokyo, Japan)2022

Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic Diseases.

Kaichi Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.